Leerink Partnrs Has Bearish Forecast for VYGR Q2 Earnings
Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) – Equities researchers at Leerink Partnrs reduced their Q2 2025 EPS estimates for shares of Voyager Therapeutics in a research report issued on Tuesday, May 6th. Leerink Partnrs analyst L. Nsongo now expects that the company will post earnings of ($0.45) per share for the quarter, down from […]
Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) – Equities researchers at Leerink Partnrs reduced their Q2 2025 EPS estimates for shares of Voyager Therapeutics in a research report issued on Tuesday, May 6th. Leerink Partnrs analyst L. Nsongo now expects that the company will post earnings of ($0.45) per share for the quarter, down from […]
